Evaluation of the National Anti-Drug Strategy

Table of Contents

ADSI
Anti-Drug Strategy Initiative
CBSA
Canada Border Services Agency
CCSA
Canadian Centre on Substance Abuse
CDSA
Controlled Drugs and Substances Act
CDSS
Canadian Drugs and Substances Strategy
CICAD
Inter-American Drug Abuse Control Commission
CIHR
Canadian Institutes of Health Research
CISC
Criminal Intelligence Service Canada
Clanlabs
Clandestine Laboratories
CRA
Canada Revenue Agency
CRISM
Canadian Research Initiative in Substance Misuse
CSC
Correctional Service Canada
CTADS
Canadian Tobacco, Alcohol and Drugs Survey
DAS
Drug Analysis Service
DSCIF
Drug Strategy Community Initiatives Fund
DTC
Drug Treatment Court
DTCFP
Drug Treatment Court Funding Program
DTFP
Drug Treatment Funding Program
FAMG
Forensic Accounting Management Group
FINTRAC
Financial Transactions and Reports Analysis Centre of Canada
FNIHB
First Nations and Inuit Health Branch
FPPE
Federal Policing Public Engagement
GAC
Global Affairs Canada
HC
Health Canada
Justice Canada
Department of Justice Canada
KE
Knowledge Exchange
KES
Knowledge Exchange Strategy
LGBTQ2
Lesbian, Gay, Bisexual, Transgender, Intersex, Queer and Two-Spirit
MDMA
Methylenedioxymethamphetamine (ecstasy)
MGOs
Marihuana Grow Operations (Grow-Ops)
MMPs
Mandatory Minimum Penalties
MMT
Methadone Maintenance Treatment
MWT
Mental Wellness Team
NADS or the Strategy
National Anti-Drug Strategy
OAS
Organization of American States
OCS
Office of Controlled Substances
PBC
Parole Board of Canada
PDA
Prescription Drug Abuse
PMP
Prescription Monitoring Program
PS
Public Safety Canada
PSPC
Public Services and Procurement Canada
RCMP
Royal Canadian Mounted Police